Urinary Retention After Arthroplasty

NCT ID: NCT04707001

Last Updated: 2024-02-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

170 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-01

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Arthroplasty increases the risk of postoperative urinary retention. Treatment of postoperative urinary retention is indwelling or intermittent catheterization. The need for catheterization is most commonly determined with an ultrasound scanner. Catheterization increases the risk of urinary tract infection, which may further lead to haematogenic infection of the artificial joint. There is no evidence of an optimal way to monitor the onset of spontaneous urination.

The aim of the study is to determine whether monitoring the onset of spontaneous urination after fast track knee arthroplasty is safe based on symptoms alone without ultrasound monitoring.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Adult patients undergoing knee arthroplasty will be recruited to this study. Participants will be randomized to the ultrasound monitoring group or the symptoms alone group. In the symptoms alone group, urination is monitored by asking at regular intervals about the onset of spontaneous urination and the patient is catheterized only on a symptomatic basis or if spontaneous voiding has not started 10 hours after the spinal anesthesia. Symptoms that indicate catheterization are lower abdominal pain or need to void. In the ultrasound group, urinary retention is monitored according to current practice with an ultrasound scanner and the patient is catheterized if residual urine exceeds 800 ml or if the patient is symptomatic.

The primary outcome variable is the change in IPSS score from the baseline to 3 months after the procedure. The baseline score is evaluated preoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Retention Postoperative Arthroplasty Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

open label
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ultrasound monitoring group

In the ultrasound group, urinary retention is monitored, according to current practice, with an ultrasound scanner and the patient is catheterized if necessary, if residual urine exceeds 800 ml, or if the patient is symptomatic.

Group Type ACTIVE_COMPARATOR

Catheterization based on ultrasound

Intervention Type OTHER

Bladder volume ultrasound

Symptoms alone group

Urination is monitored by asking at regular intervals about the onset of spontaneous urination and the patient is catheterized only on a symptomatic basis.

Group Type ACTIVE_COMPARATOR

Catheterization based on evaluation of symptoms

Intervention Type OTHER

Ask for symptoms: Need to urinate, lower abdominal pain

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Catheterization based on ultrasound

Bladder volume ultrasound

Intervention Type OTHER

Catheterization based on evaluation of symptoms

Ask for symptoms: Need to urinate, lower abdominal pain

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* elective total knee arthroplasty

Exclusion Criteria

* previous surgery for urologic cancer
* fracture as indication for surgery
* lack of co-operation
* untreated urinary retention
* nephrostoma
* general anesthesia
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Eastern Finland

OTHER

Sponsor Role collaborator

Central Finland Hospital District

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juha Paloneva, professor

Role: PRINCIPAL_INVESTIGATOR

Chief medical director

Heikki Seikkula, PhD

Role: STUDY_CHAIR

Investigator

Juho Sippola, MD

Role: STUDY_CHAIR

Investigator

Konsta Pamilo, PhD

Role: STUDY_CHAIR

Investigator

Jonne Åkerla, MD

Role: STUDY_CHAIR

Investigator

Aleksi Reito, PhD

Role: STUDY_CHAIR

Investigator

Pirkko Kinnunen

Role: STUDY_CHAIR

Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Finland Hospital Nova

Jyväskylä, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Juha Paloneva, professor

Role: CONTACT

014 269 1680

Juho Sippola, MD

Role: CONTACT

014 269 1908

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Juha Paloneva, MD, PhD

Role: primary

+358 14 2693119

Juho Sippola, MD

Role: backup

+358 14 2691908

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1U/2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Opening Wedge High Tibial Osteotomy
NCT03448796 TERMINATED NA
Substitution of the PCL in TKA With UC or PS Design
NCT04679857 ACTIVE_NOT_RECRUITING NA